Transapical implantation of the transcatheter heart valve MyVal in CHUAC
Considering the great importance that the transcatheter aortic valve replacement (TAVR) has nowadays in the treatment of valvular heart disease, Cardiolink Group has recently reached an agreement with Meril Life Sciences Pvt. Ltd, for the distribution of the transcatheter heart valve MyValTM in Spain. The transcatheter aortic valve replacement (TAVR), is a minimally invasive surgical [...]